BIBLIOGRAPHIC RECORD

Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Jamie E. Chaft; Geoffrey R. Oxnard; Camelia S. Sima; Mark G. Kris; Vincent A. Miller; Gregory J. Riely
Source of metadata
OpenAlex
Year recorded
2011

Public identifiers and source

Open the source record

Reference

Jamie E. Chaft; Geoffrey R. Oxnard; Camelia S. Sima; Mark G. Kris; Vincent A. Miller; Gregory J. Riely. (2011). Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design. https://openalex.org/W2128208856

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.